CD22L与胰岛素的结合减弱了胰岛素特异性B细胞激活
Kyle D Apley1, Amber S Griffith2, Grant M Downes3
1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
Bioconjugate chemistry
|October 26, 2023
概括
针对抗胰岛素B细胞的新双功能分子对预防1型糖尿病 (T1D) 有望. 单体结合物减少了致病性B细胞的激活,而不会损害正常细胞,这表明了潜在的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 生物技术是生物技术.
背景情况:
- 胰腺小岛反应性B淋巴细胞通过向T细胞呈现抗原来驱动1型糖尿病 (T1D).
- 目前的治疗方法,如Teplizumab提供部分保护,需要新的策略来完全预防疾病.
- 准特定的B细胞种群为T1D提供了潜在的治疗途径.
研究的目的:
- 设计和评估用于选择性抑制T1D促进抗胰岛素B细胞的双功能分子.
- 为了研究胰岛素-CD22L结合剂在调节B细胞活性方面的疗效.
- 评估这些合物作为T1D预防疗法的潜力.
主要方法:
- 合成了两种胰岛素-CD22L合原型:一个多价值的2:2合在PEG骨干上和一个单质的1:1直接合.
- 在体外测试中使用来自表达抗胰岛素B细胞受体 (BCRs) 的转基因小鼠的B细胞.
- 评估B细胞增殖和激活 (CD86上调) 通过流细胞计,与或没有模拟的T细胞帮助 (抗CD40).
主要成果:
- 多价合物 (2:2胰岛素-CD22L在PEG上) 显示B细胞激活,类似于对照组,表明BCR交叉链接.
- 单体1: 1胰岛素-CD22L合物在T细胞的存在下显著降低了抗胰岛素B细胞的增殖和激活.
- 构造物没有影响野生型B细胞,表明特异性,单独的CD22L没有影响.
结论:
- 单体抗原-CD22L结合物有效地降低了致病性B细胞的激活和数量,而不会诱导一般免疫缺陷.
- 这些发现凸显了单质胰岛素-CD22L合物的潜力,作为T1D预防的有前途的战略.
- 进一步的临床前研究是有必要的,以推动这些结合物进入临床试验.
更多相关视频
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
T Cell Activation and Clonal Selection
764
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
764


